期刊文献+

甲状腺癌基因治疗的现状及展望 被引量:16

原文传递
导出
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2005年第2期255-256,共2页 Chinese Journal of Experimental Surgery
  • 相关文献

参考文献10

  • 1宋光,铁轶,黄晓明,蓝光会,孙志贤,李荣.中国人甲状腺乳头状癌中RET基因重排及类型的分析研究[J].中华实验外科杂志,2004,21(4):422-424. 被引量:11
  • 2何松青,陈孝平.肿瘤坏死因子相关凋亡诱导配体治疗肿瘤存在的问题及策略[J].中华实验外科杂志,2003,20(10):958-960. 被引量:3
  • 3Drosten M,Stiewe T,Putzer BM.Antitumor capacity of a dominant-negative RET proto-oncogene mutant in a medullary thyroid carcinoma model.Hum Gene Ther,2003,14:971-982. 被引量:1
  • 4Takeda T,Inaba H,Yamazaki M,et al.Tumor-specific gene therapy for undifferentiated thyroid carcinoma utilizing the telomerase reverse transcriptase promoter.The journal of Clinical Endocrinology & Metabolism,2003,88:3531-3538. 被引量:1
  • 5Zhang R,DeGroot LJ.An adenoviral vector expressing functional heterogeneous proteins,herpes simplex viral thymidine kinase and human interleukin-2 has enhanced in vivo antitumor activity against medullary thyroid carcinoma.Endocr Relat Cancer,2001,8:315-325. 被引量:1
  • 6Zhang R,DeGroot LJ.Gene therapy of a rat follicucular thyroid carcinoma model with adenviral vectors transducing murinernter leukin-12.Endocrinology,2003,144:1393-1398. 被引量:1
  • 7Nagayama Y,Yokoi H,Takeda K,et al.Adenovirus-Mediated tumor suppressor p53 gene therapy for anaplastic thyroid carcinoma in vitro and in vivo.J Clin Endocrinol Metab,2000,85:4081-4086. 被引量:1
  • 8Ye C,Feng C,Wang S,et al.sFlt-1 gene therapy of follicular thyroid carcinoma.Endocrinology,2004,145:817-822. 被引量:1
  • 9Patel A,Jhiang S,Dogra S,et al.Differentiated thyroid carcinoma that express sodium-iodide symporter have a lower risk of recurrence for children and adolescents.Pediatr Res,2002,52:737-744. 被引量:1
  • 10Kitazono M,Robery R,Zhan Z,et al.Low concentrations of the histone deacetylase inhibitor,depsipeptide(FR901228),increase expression of the Na(+)/I(-) symptorter and iodide accumulation in poorly differentiated thyroid carcinoma cells.J Clin Endocrinol Metab,2001,86:3430-3435.?A 被引量:1

二级参考文献4

  • 1Gliniak B, Tiep Le. Tumor necrosis factorrelaed apoptosis-inducing ligand ' s antitumor activity in vivo is enhanced by the chemotherapeutic agent CPT-11. Cancer Res, 1999, 59:6153. 被引量:1
  • 2Jo M, Kim TH, Seol DW, et al. Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand. Nat Med, 2000, 6: 563-567. 被引量:1
  • 3Hopkins-Donaldson S, Bodmer JL, Bourloud KB, et al. Loss of Caspase-8 expression in highly malignant human neuroblastoma cells correlates with resistance to tumor necrosis factor-related apoptosis-indueing ligand-induced apoptosis. Cancer Res, 2000, 60:4315-4319. 被引量:1
  • 4T. Yokota,T. Nakata,S. Minami,J. Inazawa,M. Emi. Genomic organization and chromosomal mapping of ELKS, a gene rearranged in a papillary thyroid carcinoma[J] 2000,Journal of Human Genetics(1):6~11 被引量:1

共引文献12

同被引文献142

引证文献16

二级引证文献96

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部